vol1 - Page 186

Page 186 Previous , Next , Original Image
Return to Index

 Mexico found resistance and an uncooperative attitude in FDA,
 which lasted for several months during _ich time several New
 Mexico patients waiting to receive care died. Realizing that FDA
 was not responding to its efforts, New Mexico officials
 considered alternative ways to implement the program avoiding FDA
 completely° An option considered was the use of confiscated
 supplies of marijuana held by the local police department. It
 was onlywhen New Mexico officials made FDA aware of these plans
 and indicated the state was prepared to publicly expose FDA's
 inaction, the New Mexico program received FDA approval. The
 program approved_ as noted abovee was not a double-blinds random
 testing procedure but one where patients and physicians retained
 ultimate control over the selection of drugs. This program
 finally approved, labeled as a _compromise approach, _ came closer
 to the intent of the New Mexico legislature. _7!/
 b. Other Leaal Or_anizatioD_
 A number of legal organizations have recognized
 marijuana#s medical use in the treatment of emesis. The National
 Association of Attorneys General (_NAAG _) issued a resolution in
 June, 1983_ whereby, based on the existing scientific and medical
 reports, it called on Congress and administrative bodies to
 7_/ Affidavit of George Goldstein, _ 22-44. See i!l__q on the
 Louisiana program, Affidavit of Dr_ John Bickers_ _ I0, 12
 (inability to create viable program for treatment of cancer _
 patients due to mdisconcertingm attitude of federal officials)_
 Affidavit of Dro Philip Jobe_ _ 23 (lack of adequate response
 from FDA to state efforts to establish program of patient care);
 on California program, Affidavit of Dr. Ivan Silverberg_ _ 77
 (lack of treatment flexibility in executi_on of program was
 contrary to spirit of the state law) o
 - 113 --

Previous , Next , Return to Index